Cogni Labs Limited
About Cogni Labs Limited
Data last updated:
Cogni Labs Limited is a public limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21000DL2016PLC291734.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Ashutosh Goel and Naresh Kumar Goel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. – 8 Room No. – 3 First Floor, Printing Press Area Wazirpur, Delhi, India – 110035.
As per the financials filed for FY 2025, the company reported a revenue of ₹89,387, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹22,121 (net margin 24.7%) and EBITDA of ₹26,893 (EBITDA margin 30.1%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. – 8 Room No. – 3 First Floor, Printing Press Area Wazirpur, Delhi, India – 110035
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Cogni Labs Limited FY 2025 filings available
Cogni Labs Limited reported revenue of ₹89,387 (up 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Cogni Labs Limited
Revenue rose 21% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 439% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Cogni Labs Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹26,893 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹22,121 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Cogni Labs Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 30.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 24.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cogni Labs are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Cogni Labs Limited
Cogni Labs Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Panaaya Pharma Private Limited | ₹91,650 (FY 2025) | •••• | •••• | -67.0% | •••• | Secunderabad, Telangana, India |
| Biopeak Lifescience Private Limited | ₹91,218 (FY 2025) | •••• | •••• | 12.0% | •••• | Mumbai, Maharashtra, India |
| Grace N Glory Medical Private Limited | ₹90,733 (FY 2025) | •••• | •••• | -97.0% | •••• | Kolhapur, Maharashtra, India |
| Vancure Pharma Private Limited | ₹90,594 (FY 2021) | •••• | •••• | 192.0% | •••• | Unchahar, Uttar Pradesh, India |
| CPD Pharma Private Limited | ₹90,000 (FY 2025) | •••• | •••• | -100.0% | •••• | Chennai, Tamil Nadu, India |
| Cogni Labs Limited this company | ₹89,387 (FY 2025) | •••• | •••• | 21.0% | •••• | Delhi, India |
| Bismed Health Care Private Limited | ₹87,865 (FY 2025) | •••• | •••• | -5.0% | •••• | Muzaffarpur, Bihar, India |
| Mercure Pharmaceuticals (OPC) Private Limited | ₹85,541 (FY 2025) | •••• | •••• | 4.0% | •••• | Indore, Madhya Pradesh, India |
| Rising Life Science Private Limited | ₹85,000 (FY 2021) | •••• | •••• | -46.0% | •••• | Vadodara, Gujarat, India |
| Archana Pharmaceuticals Private Limited | ₹84,150 (FY 2024) | •••• | •••• | -45.0% | •••• | New Delhi, Delhi, India |
| RGM Trading Private Limited | ₹84,000 (FY 2024) | •••• | •••• | -30.0% | •••• | Thane, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Cogni Labs by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Cogni Labs Limited
Cogni Labs has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashutosh Goel Also directs: Cogni Pharmaceuticals LLP, Gangesh Renewable Energy LLP, Gangesh Reality LLP and 4 more | Director | 15 Dec 2016 | 9 Years 9 Months | Current |
| Naresh Kumar Goel Also directs: Sun Medilab LLP, Cogni Pharmaceuticals LLP, Warner India Lifesciences Limited and 5 more | Director | 25 Feb 2016 | 10 Years 7 Months | Current |
| Mayank Goel Also directs: Cogni Pharmaceuticals LLP, Gangesh Renewable Energy LLP, Gangesh Reality LLP and 5 more | Director | 15 Dec 2016 | 9 Years 9 Months | Current |
| Pranav Trikha Also directs: Meeracle Apparel LLP, P & U Retail LLP | Director | 01 Sep 2025 | 1 Years 1 Months | Current |
Charges & Borrowings of Cogni Labs Limited
Cogni Labs Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Cogni Labs Limited
Employment history and EPFO contributions of people linked to Cogni Labs.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Cogni Labs Limited
Cogni Labs has one previous CIN (Corporate Identification Number): U24233DL2016PLC291734. The current CIN is U21000DL2016PLC291734, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U21000DL2016PLC291734 | Current |
| U24233DL2016PLC291734 | Previous |
Recent Activity on Cogni Labs Limited
Cogni Labs Limited has 8 board changes on record since 2016: 4 appointments and 4 cessations. The latest: Pranav Trikha was appointed as Director on 01 Sep 2025.
Credit Ratings, Litigation & Regulatory Alerts for Cogni Labs Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cogni Labs Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cogni Labs Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Cogni Labs Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cogni Labs Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cogni Labs Limited
Cogni Labs is an active public limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 February 2016 (10+ years old) and is registered under CIN U21000DL2016PLC291734.
Cogni Labs reported revenue of ₹89,387 for FY 2025 (up 21% YoY).
Cogni Labs has 4 current directors:
- Ashutosh Goel - Director
- Naresh Kumar Goel - Director
- Mayank Goel - Director
- Pranav Trikha - Director
Cogni Labs reported a net profit of ₹22,121 (net margin 24.7%) and EBITDA of ₹26,893 (EBITDA margin 30.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Cogni Labs is -1% over three years and -2% over five years. In the latest year (FY 2025) revenue rose 21%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Cogni Labs is U21000DL2016PLC291734. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cogni Labs was incorporated on 25 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Cogni Labs by revenue are Panaaya Pharma Private Limited, Biopeak Lifescience Private Limited, Grace N Glory Medical Private Limited, Vancure Pharma Private Limited, CPD Pharma Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Pranav Trikha was appointed as Director on 01 Sep 2025. Ashutosh Goel ceased to be Additional Director on 25 Sep 2017. Mayank Goel ceased to be Additional Director on 25 Sep 2017. Cogni Labs has 8 board changes on record in total.
The registered office of Cogni Labs is at Plot No. – 8 Room No. – 3 First Floor, Printing Press Area Wazirpur, Delhi, India – 110035.
Cogni Labs has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh.